Treatment for Acute Gout
First-line treatment for acute gout includes NSAIDs, oral colchicine, or corticosteroids, which should be initiated within 24 hours of symptom onset for optimal outcomes. 1, 2
First-Line Treatment Options
NSAIDs
- Use full FDA-approved anti-inflammatory doses until the gouty attack has completely resolved 1
- FDA-approved NSAIDs for acute gout include naproxen (500mg twice daily), indomethacin, and sulindac 1, 3
- Contraindicated in patients with renal disease, heart failure, or cirrhosis 1, 4
- Associated with gastrointestinal toxicity, including risk of bleeding, ulceration, and perforation 4, 5
Colchicine
- Most effective when started within 36 hours of symptom onset 6, 2
- Recommended low-dose regimen: 1.2 mg at first sign of flare, followed by 0.6 mg one hour later (maximum 1.8 mg over a one-hour period) 1, 7
- Low-dose regimen is as effective as higher doses with fewer gastrointestinal side effects 1, 7
- Common side effects include diarrhea, nausea, vomiting, cramps, and abdominal pain 1, 4
- Contraindicated in patients with severe renal or hepatic impairment who are using potent CYP3A4 inhibitors or P-glycoprotein inhibitors 1, 7
Corticosteroids
- Considered first-line therapy in patients without contraindications due to their safety profile and low cost 1, 2
- Options include:
- Contraindicated in patients with systemic fungal infections 1
Treatment Selection Considerations
Patient-Specific Factors
- Renal function: Avoid NSAIDs and adjust colchicine dose in renal impairment 4, 7
- Cardiovascular disease: Consider colchicine or corticosteroids over NSAIDs 4
- Gastrointestinal risk: Avoid NSAIDs or use with gastroprotection 4
- Diabetes: Use corticosteroids with caution due to potential hyperglycemia 1
Severity of Attack
- For severe or polyarticular attacks, combination therapy may be appropriate 1, 4
- Acceptable combination approaches include:
- Colchicine and NSAIDs
- Oral corticosteroids and colchicine
- Intra-articular steroids with any other modality 1
Important Principles
- Initiate treatment within 24 hours of symptom onset for best outcomes 1, 2
- Continue urate-lowering therapy (if already prescribed) during the acute attack 1, 6
- For inadequate response (defined as <20% improvement in pain score within 24 hours or <50% at ≥24 hours), consider adding a second agent 1
- Continue treatment at full dose until the gouty attack has completely resolved 1
Common Pitfalls to Avoid
- Delaying treatment initiation, which reduces effectiveness of all options 4, 2
- Using high-dose colchicine regimens, which have similar efficacy but significantly more side effects than low-dose regimens 1, 7
- Discontinuing urate-lowering therapy during acute flares 1, 2
- Failing to adjust colchicine dosing in patients with renal impairment or those taking interacting medications 4, 7
- Not considering drug interactions, particularly with colchicine 6, 7